Kuriakose Emil — SEC insider filings
SEC reporting owner CIK 1892413. 17 insider filings on record with FilingPulse; latest filed 2026-11-03.
Transaction summary — filings shown
Covers all 17 filings on record, filed 2021-11-09 to 2026-11-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 7 legs across 6 filings — 9,327 shares, $133,265 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 19.
- Largest priced transaction: sale of 942 shares @ $52.75 ($49,693) in Terns Pharmaceuticals, Inc., filed 2026-04-02.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Terns Pharmaceuticals, Inc. (TERN) | Chief Medical Officer | 10 | — | 7 legs · 9,327 sh · $133,265 | 11 |
| Calithera Biosciences, Inc. (CALA) | CHIEF MEDICAL OFFICER | 5 | — | — | 6 |
| MACROGENICS INC (MGNX) | Director | 2 | — | — | 2 |
Insider filings — Kuriakose Emil
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-03 | 4 | MACROGENICS INC (MGNX) | Grant/award (A): 44,000 (derivative) @ $0 · Grant/award (A): 7,500 (derivative) @ $0 | EDGAR |
| 2026-11-03 | 3 | MACROGENICS INC (MGNX) | Holdings only — no transactions reported | EDGAR |
| 2026-05-05 | 4 | Terns Pharmaceuticals, Inc. (TERN) | Code (U): 24,562 @ $53 · Disposition to issuer (D): 81,953 @ $53 · Disposition to issuer (D): 485,000 (derivative) · Disposition to issuer (D): 117,500 (derivative) · Disposition to issuer (D): 120,000 (derivative) · Disposition to issuer (D): 280,000 (derivative) · +1 more | EDGAR |
| 2026-04-02 | 4 | Terns Pharmaceuticals, Inc. (TERN) | Sale (S): 942 @ $52.75 | EDGAR |
| 2026-01-16 | 4 | Terns Pharmaceuticals, Inc. (TERN) | Grant/award (A): 56,250 @ $0 · Grant/award (A): 112,500 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Terns Pharmaceuticals, Inc. (TERN) | Sale (S): 200 @ $39.60 · Sale (S): 955 @ $38.36 | EDGAR |
| 2025-10-02 | 4 | Terns Pharmaceuticals, Inc. (TERN) | Sale (S): 944 @ $7.85 | EDGAR |
| 2025-07-03 | 4 | Terns Pharmaceuticals, Inc. (TERN) | Sale (S): 853 @ $4.27 | EDGAR |
| 2025-04-02 | 4 | Terns Pharmaceuticals, Inc. (TERN) | Sale (S): 952 @ $2.49 | EDGAR |
| 2025-02-03 | 4 | Terns Pharmaceuticals, Inc. (TERN) | Grant/award (A): 485,000 (derivative) @ $0 | EDGAR |
| 2025-01-06 | 4 | Terns Pharmaceuticals, Inc. (TERN) | Sale (S): 4,481 @ $5.71 | EDGAR |
| 2024-12-16 | 4 | Terns Pharmaceuticals, Inc. (TERN) | Grant/award (A): 120,000 (derivative) @ $0 | EDGAR |
| 2023-01-25 | 4 | Calithera Biosciences, Inc. (CALA) | Tax withholding (F): 79 @ $0.45 | EDGAR |
| 2022-01-27 | 4 | Calithera Biosciences, Inc. (CALA) | Grant/award (A): 215,000 (derivative) @ $0 | EDGAR |
| 2022-01-25 | 4 | Calithera Biosciences, Inc. (CALA) | Tax withholding (F): 666 @ $0.49 | EDGAR |
| 2022-01-06 | 4 | Calithera Biosciences, Inc. (CALA) | Tax withholding (F): 3,855 @ $0.66 | EDGAR |
| 2021-11-09 | 4 | Calithera Biosciences, Inc. (CALA) | Grant/award (A): 12,000 @ $0 · Tax withholding (F): 3,077 @ $0.87 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-05-18 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1892413 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs